Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2-Reference-Cited by-同舟云学术

Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2

Published:2022-01-17 Issue:4 Volume:36 Page:1048-1057
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Yang Jing^ORCID,Weisberg Ellen L.^ORCID,Qi Shuang,Ni Wei^ORCID,Mei Husheng,Wang Zuowei,Meng Chengcheng,Zhang Shengzhe,Hou Mingqi,Qi Ziping,Wang Aoli,Jiang Yunyun,Jiang Zongru,Huang Tao,Liu Qingwang,Magin Robert S.,Doherty Laura,Wang Wenchao,Liu Jing^ORCID,Buhrlage Sara J.^ORCID,Liu Qingsong^ORCID,Griffin James D.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01494-w.pdf

Reference69 articles.

1. Czermin B, Melfi R, McCabe D, Seitz V, Imhof A, Pirrotta V. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell. 2002;111:185–96.

2. Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469:343–9.

3. Liu X, Wu Q, Li L. Functional and therapeutic significance of EZH2 in urological cancers. Oncotarget. 2017;8:38044–55.

4. Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22:128–34.

5. Lunning MA, Green MR. Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas. Blood cancer J. 2015;5:e361.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

2. EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer;Biomedicine & Pharmacotherapy;2024-06

3. EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axis;Cell Reports;2024-02

4. USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis;Journal of Clinical Investigation;2023-12-01

5. Ubiquitin-specific peptidase 47 (USP47) regulates cutaneous oxidative injury through nicotinamide nucleotide transhydrogenase (NNT);Toxicology and Applied Pharmacology;2023-12